The global report titled as Dengue Drugs Market has recently published by Absolute markets Insights to its huge repository. This research report involves massive data which can influence the development of the Dengue Drugs market. This discovery report provides powerful data that can guide you in managing the risks and challenges faced by enterprises. It covers the major recent trends that are influencing the growth of the global Dengue Drugs market. Different technologies around the globe make an impact on the Dengue Drugs market. The analysts in this research report used primary and secondary research methods to effectively study the market.
Top Key Players includes: AbbVie Inc., ABIVAX, GSK group of companies, Johnson & Johnson Services, Inc., Micro Labs Ltd., Pfizer Inc., Sanofi, Sun Pharma and Takeda Pharmaceutical Company Limited
Global Dengue Drugs Market is expected to grow at a CAGR of +2.6% from 2021 to 2030
Click to view the full report: https://www.absolutemarketsinsights.com/reports/Dengue-Drugs-Market-617
The reported cases of dengue to World Health Organization in 2019 were 4.2 million and are spreading to multiple countries. This high number of patients has triggered numerous research and development activities for developing effective and economical dengue drugs. For instance, Indian Ministry of Science and Technology in partnership with Sun Pharmaceutical Industries Ltd. developed an herbal medicine for dengue in 2019.
Similarly, 60 Degrees Pharmaceuticals of Singapore was granted a patent for a novel dengue drug named Celgosivir in 2014. These on-going developments of newer drugs are anticipated to drive the global dengue drugs market in forecast years. The maximum potential market for dengue drugs is US $338 million per year. Over 2-3 billion of the world’s population is at risk of contracting dengue. Approximately 3–6% of clinical cases progress from an acute but uncomplicated febrile form of the disease to dengue hemorrhagic fever or dengue shock syndrome. This manifestation is reported to be fatal in nature. Drugs are a intervention that may be useful for patients who contract dengue because they did not receive an approved dengue vaccine or for whom prior vaccination was ineffective.
Global Dengue Drugs Market: Report Scope
By Distribution Channel
- Hospitals
- Clinics
- Pharmacies
- Others
By Type
- Rx
- OTC
By Drug Class
- Acetaminophen
- Rehydration therapy
- Others
By Route of Administration
- Oral
- Intravenous
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
No comments:
Post a Comment